Alcon Inc (ALC)

Feb 27, 2025, 9:02 AM EST - 9 days ago

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

Feb 26, 2025, 8:54 PM EST - 10 days ago

Watch CNBC's full interview with Alcon CEO David Endicott

Feb 26, 2025, 11:51 AM EST - 10 days ago

Alcon Inc. (ALC) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 2:13 AM EST - 10 days ago

Alcon eyes revenue growth in 2025 after in-line results

Feb 25, 2025, 4:30 PM EST - 11 days ago

Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation

Feb 24, 2025, 8:02 AM EST - 12 days ago

Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet

Feb 19, 2025, 8:02 AM EST - 17 days ago

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension

Dec 31, 2024, 4:30 PM EST - 2 months ago

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Nov 14, 2024, 12:17 AM EST - 4 months ago

Alcon: Q3, Slight Guidance Cut Is Not Something Structural

Nov 13, 2024, 12:24 PM EST - 4 months ago

Alcon (ALC) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:17 AM EST - 4 months ago

Alcon cuts 2024 forecasts, as slow US hits surgical unit

Nov 12, 2024, 12:10 PM EST - 4 months ago

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

Oct 15, 2024, 2:04 PM EDT - 5 months ago

Aging population creates opportunity in these healthcare stocks, says Thornburg's Leveille

LLY NVO

Aug 22, 2024, 12:00 PM EDT - 7 months ago

Alcon Analysts Increase Their Forecasts After Q2 Results

Aug 22, 2024, 10:54 AM EDT - 7 months ago

Alcon CEO: 'Very good' revenue and underlying demand in Q2

Aug 21, 2024, 12:05 PM EDT - 7 months ago

Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 4:30 PM EDT - 7 months ago

Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses

Jun 24, 2024, 1:00 AM EDT - 9 months ago

Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

May 14, 2024, 10:48 AM EDT - 10 months ago

Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:30 PM EDT - 10 months ago

Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

May 8, 2024, 4:30 PM EDT - 10 months ago

Alcon Announces Results of 2024 Annual General Meeting

Apr 7, 2024, 5:59 PM EDT - 11 months ago

Alcon Publishes Agenda for 2024 Annual General Meeting

Mar 6, 2024, 9:55 AM EST - 1 year ago

Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone

Feb 28, 2024, 9:45 PM EST - 1 year ago

Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:30 PM EST - 1 year ago

Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023

Nov 15, 2023, 11:56 AM EST - 1 year ago

Alcon Inc. (ALC) Q3 2023 Earnings Call Transcript

Nov 15, 2023, 8:49 AM EST - 1 year ago

Alcon's stock falls as third-quarter sales miss estimates

Nov 14, 2023, 4:30 PM EST - 1 year ago

Alcon Reports Third Quarter 2023 Results

Oct 10, 2023, 1:03 PM EDT - 1 year ago

Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales

Aug 16, 2023, 11:29 AM EDT - 1 year ago

Alcon Inc. (ALC) Q2 2023 Earnings Call Transcript

Aug 15, 2023, 4:30 PM EDT - 1 year ago

Alcon Reports Second Quarter 2023 Results

Jul 26, 2023, 4:33 AM EDT - 1 year ago

Alcon: Lackluster Growth Given Its Valuation

Jun 27, 2023, 6:49 PM EDT - 1 year ago

Alcon: The Steady Force Of 'Boring'

May 11, 2023, 9:38 AM EDT - 1 year ago

Alcon CEO: Aging population and new technology driving eyecare business forward

May 9, 2023, 4:34 PM EDT - 1 year ago

Alcon Reports First Quarter 2023 Results

Mar 23, 2023, 9:05 AM EDT - 2 years ago

Alcon's “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Feb 28, 2023, 12:54 PM EST - 2 years ago

Alcon Inc. (ALC) Q4 2022 Earnings Call Transcript

Feb 27, 2023, 4:30 PM EST - 2 years ago

Alcon Reports Fourth Quarter and Full Year 2022 Results

Feb 2, 2023, 8:01 AM EST - 2 years ago

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Feb 1, 2023, 12:32 PM EST - 2 years ago

Alcon: Case Of Growth Destructive To Value, Reiterate Hold At 24x Earnings

Jan 5, 2023, 1:05 AM EST - 2 years ago

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Dec 28, 2022, 10:05 AM EST - 2 years ago

Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference

Nov 29, 2022, 8:30 PM EST - 2 years ago

Alcon Prices US$1.3 Billion Senior Notes Offering

Nov 22, 2022, 1:01 AM EST - 2 years ago

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business

Nov 18, 2022, 2:31 AM EST - 2 years ago

Alcon: Eyeing A Growth Story That Could Benefit From A Weaker Dollar

Nov 16, 2022, 12:30 PM EST - 2 years ago

Alcon Inc. (ALC) Q3 2022 Earnings Call Transcript

Nov 15, 2022, 4:30 PM EST - 2 years ago

Alcon Reports Third Quarter 2022 Results

Oct 26, 2022, 1:46 PM EDT - 2 years ago

Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22

Oct 14, 2022, 6:18 PM EDT - 2 years ago

AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI

Sep 29, 2022, 9:02 AM EDT - 2 years ago

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022